actually, to avoid any "loopholes" the question should be "how long ago, and by whom was the replacement of the extruder raised?" If you add "...for the purpose of sales collateral", this gives the company scope to deem that at the time it wouldnt add to sales collateral (which evidenced by their statements now, does.)
- Forums
- ASX - By Stock
- top strategic move by top team
actually, to avoid any "loopholes" the question should be "how...
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ECT (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.343M |
Open | High | Low | Value | Volume |
0.2¢ | 0.2¢ | 0.2¢ | $1 | 406 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
65 | 34296227 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 13986530 | 33 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
64 | 33996227 | 0.002 |
28 | 37002532 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 9825223 | 32 |
0.004 | 7713019 | 12 |
0.005 | 3676859 | 23 |
0.006 | 3178567 | 7 |
0.007 | 918333 | 2 |
Last trade - 13.39pm 04/10/2024 (20 minute delay) ? |
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
NEWS
Breakthrough programs slash healthcare events, driving a significant A$1.8M+ annual revenue boost
ECT (ASX) Chart |